132 related articles for article (PubMed ID: 32247748)
1. A chemically stable peptide agonist to neuromedin U receptor type 2.
Takayama K; Mori K; Tanaka A; Sasaki Y; Sohma Y; Taguchi A; Taniguchi A; Sakane T; Yamamoto A; Miyazato M; Minamino N; Kangawa K; Hayashi Y
Bioorg Med Chem; 2020 May; 28(10):115454. PubMed ID: 32247748
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.
Takayama K; Mori K; Tanaka A; Nomura E; Sohma Y; Mori M; Taguchi A; Taniguchi A; Sakane T; Yamamoto A; Minamino N; Miyazato M; Kangawa K; Hayashi Y
J Med Chem; 2017 Jun; 60(12):5228-5234. PubMed ID: 28548497
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.
Takayama K; Mori K; Asari T; Sohma Y; Nomura E; Sasaki Y; Taguchi A; Taniguchi A; Miyazato M; Minamino N; Kangawa K; Hayashi Y
Bioorg Med Chem Lett; 2020 Sep; 30(18):127436. PubMed ID: 32721452
[TBL] [Abstract][Full Text] [Related]
4. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
[TBL] [Abstract][Full Text] [Related]
5. Development of potent and proteolytically stable human neuromedin U receptor agonists.
De Prins A; Martin C; Van Wanseele Y; Skov LJ; Tömböly C; Tourwé D; Caveliers V; Van Eeckhaut A; Holst B; Rosenkilde MM; Smolders I; Ballet S
Eur J Med Chem; 2018 Jan; 144():887-897. PubMed ID: 29329072
[TBL] [Abstract][Full Text] [Related]
6. A potent neuromedin U receptor 2-selective alkylated peptide.
Nishizawa N; Kanematsu-Yamaki Y; Funata M; Nagai H; Shimizu A; Fujita H; Sakamoto J; Takekawa S; Asami T
Bioorg Med Chem Lett; 2017 Oct; 27(20):4626-4629. PubMed ID: 28935264
[TBL] [Abstract][Full Text] [Related]
7. Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2.
Takayama K; Mori K; Taketa K; Taguchi A; Yakushiji F; Minamino N; Miyazato M; Kangawa K; Hayashi Y
J Med Chem; 2014 Aug; 57(15):6583-93. PubMed ID: 24999562
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression patterns of neuromedin U and its receptors in pigs.
Li X; Niu M; Su J; Ma Z; Jin M; Qiao W; Zhang Y; Feng Y; An N; Hou Y; Yang S; Chuan S; Lei Z
Neuropeptides; 2017 Aug; 64():47-60. PubMed ID: 28434792
[TBL] [Abstract][Full Text] [Related]
9. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
[TBL] [Abstract][Full Text] [Related]
10. [Medicinal Chemistry Focused on Mid-sized Peptides Derived from Biomolecules].
Takayama K
Yakugaku Zasshi; 2019; 139(11):1377-1384. PubMed ID: 31685733
[TBL] [Abstract][Full Text] [Related]
11. Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.
Kanematsu-Yamaki Y; Nishizawa N; Kaisho T; Nagai H; Mochida T; Asakawa T; Inooka H; Dote K; Fujita H; Matsumiya K; Hirabayashi H; Sakamoto J; Ohtaki T; Takekawa S; Asami T
J Med Chem; 2017 Jul; 60(14):6089-6097. PubMed ID: 28657315
[TBL] [Abstract][Full Text] [Related]
12. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
Peier A; Kosinski J; Cox-York K; Qian Y; Desai K; Feng Y; Trivedi P; Hastings N; Marsh DJ
Endocrinology; 2009 Jul; 150(7):3101-9. PubMed ID: 19324999
[TBL] [Abstract][Full Text] [Related]
13. Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor.
Przygodzka P; Sochacka E; Soboska K; Pacholczyk M; Papiewska-Pająk I; Przygodzki T; Płociński P; Ballet S; De Prins A; Boncela J
J Exp Clin Cancer Res; 2021 Sep; 40(1):283. PubMed ID: 34493299
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.
Wan Y; Zhang J; Fang C; Chen J; Li J; Li J; Wu C; Wang Y
Peptides; 2018 Mar; 101():69-81. PubMed ID: 29288685
[TBL] [Abstract][Full Text] [Related]
15. Transnasal Delivery of the Peptide Agonist Specific to Neuromedin-U Receptor 2 to the Brain for the Treatment of Obesity.
Tanaka A; Takayama K; Furubayashi T; Mori K; Takemura Y; Amano M; Maeda C; Inoue D; Kimura S; Kiriyama A; Katsumi H; Miyazato M; Kangawa K; Sakane T; Hayashi Y; Yamamoto A
Mol Pharm; 2020 Jan; 17(1):32-39. PubMed ID: 31765157
[TBL] [Abstract][Full Text] [Related]
16. PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.
Ingallinella P; Peier AM; Pocai A; Marco AD; Desai K; Zytko K; Qian Y; Du X; Cellucci A; Monteagudo E; Laufer R; Bianchi E; Marsh DJ; Pessi A
Bioorg Med Chem; 2012 Aug; 20(15):4751-9. PubMed ID: 22771182
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.
Takayama K; Mori K; Sohma Y; Taketa K; Taguchi A; Yakushiji F; Minamino N; Miyazato M; Kangawa K; Hayashi Y
ACS Med Chem Lett; 2015 Mar; 6(3):302-7. PubMed ID: 25815150
[TBL] [Abstract][Full Text] [Related]
18. Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses.
Torres R; Croll SD; Vercollone J; Reinhardt J; Griffiths J; Zabski S; Anderson KD; Adams NC; Gowen L; Sleeman MW; Valenzuela DM; Wiegand SJ; Yancopoulos GD; Murphy AJ
Pain; 2007 Aug; 130(3):267-278. PubMed ID: 17379411
[TBL] [Abstract][Full Text] [Related]
19. Two chicken neuromedin U receptors: characterization of primary structure, biological activity and tissue distribution.
Yamamoto I; Nakao N; Kaiya H; Miyazato M; Tsushima N; Arai T; Tanaka M
Gen Comp Endocrinol; 2011 Nov; 174(2):116-23. PubMed ID: 21878335
[TBL] [Abstract][Full Text] [Related]
20. Unanticipated Characteristics of a Selective, Potent Neuromedin-U Receptor 2 Agonist.
Mehrotra S; Lam S; Glenn E; Hymel D; Sanford CA; Liu Q; Herich J; Wulff BS; Meek TH
ACS Bio Med Chem Au; 2022 Aug; 2(4):370-375. PubMed ID: 37102164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
